Personal information

No personal information available

Activities

Collapse all

Works (30)

Data from Efficacy of nivolumab in pediatric cancers with high mutation burden and mismatch-repair deficiency

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.c.6678040.v3
Contributors: Anirban Das; Uri Tabori; Lauren C. Sambira Nahum; Natalie B. Collins; Rebecca Deyell; Rina Dvir; Cecile Faure-Conter; Timothy E. Hassall; Jane E. Minturn; Melissa Edwards et al.
Source: check_circle
Crossref

Data from Efficacy of nivolumab in pediatric cancers with high mutation burden and mismatch-repair deficiency

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.c.6678040
Contributors: Anirban Das; Uri Tabori; Lauren C. Sambira Nahum; Natalie B. Collins; Rebecca Deyell; Rina Dvir; Cecile Faure-Conter; Timothy E. Hassall; Jane E. Minturn; Melissa Edwards et al.
Source: check_circle
Crossref

Suppl Figure S1 from Efficacy of nivolumab in pediatric cancers with high mutation burden and mismatch-repair deficiency

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27031396
Contributors: Anirban Das; Uri Tabori; Lauren C. Sambira Nahum; Natalie B. Collins; Rebecca Deyell; Rina Dvir; Cecile Faure-Conter; Timothy E. Hassall; Jane E. Minturn; Melissa Edwards et al.
Source: check_circle
Crossref

Suppl Figure S1 from Efficacy of nivolumab in pediatric cancers with high mutation burden and mismatch-repair deficiency

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27031396.v1
Contributors: Anirban Das; Uri Tabori; Lauren C. Sambira Nahum; Natalie B. Collins; Rebecca Deyell; Rina Dvir; Cecile Faure-Conter; Timothy E. Hassall; Jane E. Minturn; Melissa Edwards et al.
Source: check_circle
Crossref

Suppl Table S2 from Efficacy of nivolumab in pediatric cancers with high mutation burden and mismatch-repair deficiency

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27031393
Contributors: Anirban Das; Uri Tabori; Lauren C. Sambira Nahum; Natalie B. Collins; Rebecca Deyell; Rina Dvir; Cecile Faure-Conter; Timothy E. Hassall; Jane E. Minturn; Melissa Edwards et al.
Source: check_circle
Crossref

Suppl Table S2 from Efficacy of nivolumab in pediatric cancers with high mutation burden and mismatch-repair deficiency

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27031393.v1
Contributors: Anirban Das; Uri Tabori; Lauren C. Sambira Nahum; Natalie B. Collins; Rebecca Deyell; Rina Dvir; Cecile Faure-Conter; Timothy E. Hassall; Jane E. Minturn; Melissa Edwards et al.
Source: check_circle
Crossref

Supplementary Table S1 from Efficacy of nivolumab in pediatric cancers with high mutation burden and mismatch-repair deficiency

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27031390
Contributors: Anirban Das; Uri Tabori; Lauren C. Sambira Nahum; Natalie B. Collins; Rebecca Deyell; Rina Dvir; Cecile Faure-Conter; Timothy E. Hassall; Jane E. Minturn; Melissa Edwards et al.
Source: check_circle
Crossref

Supplementary Table S1 from Efficacy of nivolumab in pediatric cancers with high mutation burden and mismatch-repair deficiency

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27031390.v1
Contributors: Anirban Das; Uri Tabori; Lauren C. Sambira Nahum; Natalie B. Collins; Rebecca Deyell; Rina Dvir; Cecile Faure-Conter; Timothy E. Hassall; Jane E. Minturn; Melissa Edwards et al.
Source: check_circle
Crossref

Trial protocol 1 from Efficacy of nivolumab in pediatric cancers with high mutation burden and mismatch-repair deficiency

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27031387
Contributors: Anirban Das; Uri Tabori; Lauren C. Sambira Nahum; Natalie B. Collins; Rebecca Deyell; Rina Dvir; Cecile Faure-Conter; Timothy E. Hassall; Jane E. Minturn; Melissa Edwards et al.
Source: check_circle
Crossref

Trial protocol 1 from Efficacy of nivolumab in pediatric cancers with high mutation burden and mismatch-repair deficiency

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27031387.v1
Contributors: Anirban Das; Uri Tabori; Lauren C. Sambira Nahum; Natalie B. Collins; Rebecca Deyell; Rina Dvir; Cecile Faure-Conter; Timothy E. Hassall; Jane E. Minturn; Melissa Edwards et al.
Source: check_circle
Crossref

Data from Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency

2023-12-01 | Preprint
DOI: 10.1158/1078-0432.c.6678040.v2
Contributors: Anirban Das; Uri Tabori; Lauren C. Sambira Nahum; Natalie B. Collins; Rebecca Deyell; Rina Dvir; Cecile Faure-Conter; Timothy E. Hassall; Jane E. Minturn; Melissa Edwards et al.
Source: check_circle
Crossref

Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency

Clinical Cancer Research
2023-12-01 | Journal article
DOI: 10.1158/1078-0432.CCR-23-0411
Contributors: Anirban Das; Uri Tabori; Lauren C. Sambira Nahum; Natalie B. Collins; Rebecca Deyell; Rina Dvir; Cecile Faure-Conter; Timothy E. Hassall; Jane E. Minturn; Melissa Edwards et al.
Source: check_circle
Crossref

Suppl Figure S1 from Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency

2023-12-01 | Preprint
DOI: 10.1158/1078-0432.24710479
Contributors: Anirban Das; Uri Tabori; Lauren C. Sambira Nahum; Natalie B. Collins; Rebecca Deyell; Rina Dvir; Cecile Faure-Conter; Timothy E. Hassall; Jane E. Minturn; Melissa Edwards et al.
Source: check_circle
Crossref

Suppl Figure S1 from Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency

2023-12-01 | Preprint
DOI: 10.1158/1078-0432.24710479.v1
Contributors: Anirban Das; Uri Tabori; Lauren C. Sambira Nahum; Natalie B. Collins; Rebecca Deyell; Rina Dvir; Cecile Faure-Conter; Timothy E. Hassall; Jane E. Minturn; Melissa Edwards et al.
Source: check_circle
Crossref

Suppl Table S2 from Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency

2023-12-01 | Preprint
DOI: 10.1158/1078-0432.24710476
Contributors: Anirban Das; Uri Tabori; Lauren C. Sambira Nahum; Natalie B. Collins; Rebecca Deyell; Rina Dvir; Cecile Faure-Conter; Timothy E. Hassall; Jane E. Minturn; Melissa Edwards et al.
Source: check_circle
Crossref

Suppl Table S2 from Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency

2023-12-01 | Preprint
DOI: 10.1158/1078-0432.24710476.v1
Contributors: Anirban Das; Uri Tabori; Lauren C. Sambira Nahum; Natalie B. Collins; Rebecca Deyell; Rina Dvir; Cecile Faure-Conter; Timothy E. Hassall; Jane E. Minturn; Melissa Edwards et al.
Source: check_circle
Crossref

Supplementary Table S1 from Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency

2023-12-01 | Preprint
DOI: 10.1158/1078-0432.24710473.v1
Contributors: Anirban Das; Uri Tabori; Lauren C. Sambira Nahum; Natalie B. Collins; Rebecca Deyell; Rina Dvir; Cecile Faure-Conter; Timothy E. Hassall; Jane E. Minturn; Melissa Edwards et al.
Source: check_circle
Crossref

Supplementary Table S1 from Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency

2023-12-01 | Preprint
DOI: 10.1158/1078-0432.24710473
Contributors: Anirban Das; Uri Tabori; Lauren C. Sambira Nahum; Natalie B. Collins; Rebecca Deyell; Rina Dvir; Cecile Faure-Conter; Timothy E. Hassall; Jane E. Minturn; Melissa Edwards et al.
Source: check_circle
Crossref

Trial protocol 1 from Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency

2023-12-01 | Preprint
DOI: 10.1158/1078-0432.24710470.v1
Contributors: Anirban Das; Uri Tabori; Lauren C. Sambira Nahum; Natalie B. Collins; Rebecca Deyell; Rina Dvir; Cecile Faure-Conter; Timothy E. Hassall; Jane E. Minturn; Melissa Edwards et al.
Source: check_circle
Crossref

Trial protocol 1 from Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency

2023-12-01 | Preprint
DOI: 10.1158/1078-0432.24710470
Contributors: Anirban Das; Uri Tabori; Lauren C. Sambira Nahum; Natalie B. Collins; Rebecca Deyell; Rina Dvir; Cecile Faure-Conter; Timothy E. Hassall; Jane E. Minturn; Melissa Edwards et al.
Source: check_circle
Crossref

Data from Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency

2023-06-02 | Preprint
DOI: 10.1158/1078-0432.c.6678040.v1
Contributors: Anirban Das; Uri Tabori; Lauren C. Sambira Nahum; Natalie B. Collins; Rebecca Deyell; Rina Dvir; Cecile Faure-Conter; Timothy E. Hassall; Jane E. Minturn; Melissa Edwards et al.
Source: check_circle
Crossref

Suppl Figure S1 from Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency

2023-06-02 | Preprint
DOI: 10.1158/1078-0432.23284771
Contributors: Anirban Das; Uri Tabori; Lauren C. Sambira Nahum; Natalie B. Collins; Rebecca Deyell; Rina Dvir; Cecile Faure-Conter; Timothy E. Hassall; Jane E. Minturn; Melissa Edwards et al.
Source: check_circle
Crossref

Suppl Figure S1 from Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency

2023-06-02 | Preprint
DOI: 10.1158/1078-0432.23284771.v1
Contributors: Anirban Das; Uri Tabori; Lauren C. Sambira Nahum; Natalie B. Collins; Rebecca Deyell; Rina Dvir; Cecile Faure-Conter; Timothy E. Hassall; Jane E. Minturn; Melissa Edwards et al.
Source: check_circle
Crossref

Suppl Table S2 from Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency

2023-06-02 | Preprint
DOI: 10.1158/1078-0432.23284768
Contributors: Anirban Das; Uri Tabori; Lauren C. Sambira Nahum; Natalie B. Collins; Rebecca Deyell; Rina Dvir; Cecile Faure-Conter; Timothy E. Hassall; Jane E. Minturn; Melissa Edwards et al.
Source: check_circle
Crossref

Suppl Table S2 from Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency

2023-06-02 | Preprint
DOI: 10.1158/1078-0432.23284768.v1
Contributors: Anirban Das; Uri Tabori; Lauren C. Sambira Nahum; Natalie B. Collins; Rebecca Deyell; Rina Dvir; Cecile Faure-Conter; Timothy E. Hassall; Jane E. Minturn; Melissa Edwards et al.
Source: check_circle
Crossref

Supplementary Table S1 from Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency

2023-06-02 | Preprint
DOI: 10.1158/1078-0432.23284762.v1
Contributors: Anirban Das; Uri Tabori; Lauren C. Sambira Nahum; Natalie B. Collins; Rebecca Deyell; Rina Dvir; Cecile Faure-Conter; Timothy E. Hassall; Jane E. Minturn; Melissa Edwards et al.
Source: check_circle
Crossref

Supplementary Table S1 from Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency

2023-06-02 | Preprint
DOI: 10.1158/1078-0432.23284762
Contributors: Anirban Das; Uri Tabori; Lauren C. Sambira Nahum; Natalie B. Collins; Rebecca Deyell; Rina Dvir; Cecile Faure-Conter; Timothy E. Hassall; Jane E. Minturn; Melissa Edwards et al.
Source: check_circle
Crossref

Trial protocol 1 from Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency

2023-06-02 | Preprint
DOI: 10.1158/1078-0432.23284759
Contributors: Anirban Das; Uri Tabori; Lauren C. Sambira Nahum; Natalie B. Collins; Rebecca Deyell; Rina Dvir; Cecile Faure-Conter; Timothy E. Hassall; Jane E. Minturn; Melissa Edwards et al.
Source: check_circle
Crossref

Trial protocol 1 from Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency

2023-06-02 | Preprint
DOI: 10.1158/1078-0432.23284759.v1
Contributors: Anirban Das; Uri Tabori; Lauren C. Sambira Nahum; Natalie B. Collins; Rebecca Deyell; Rina Dvir; Cecile Faure-Conter; Timothy E. Hassall; Jane E. Minturn; Melissa Edwards et al.
Source: check_circle
Crossref

An Integrative DNA Sequencing and Methylation Panel to Assess Mismatch Repair Deficiency

The Journal of Molecular Diagnostics
2021-02 | Journal article
DOI: 10.1016/j.jmoldx.2020.11.006
Contributors: Leslie E. Oldfield; Tiantian Li; Alicia Tone; Melyssa Aronson; Melissa Edwards; Spring Holter; Rene Quevedo; Emily Van de Laar; Jordan Lerner-Ellis; Aaron Pollett et al.
Source: check_circle
Crossref
How many people are using ORCID?